The Covid-19 inoculation drive by Prime Minister Narendra Modi, touted as the biggest vaccination programme of the world, rolled out across India .
The Drugs Controller General of India has approved two vaccines for the drive – Hyderabad-based Bharat Biotech’s ‘Covaxin’ developed with the help of the Indian Council of Medical Research and National Institute of Virology, and ‘Covishield’ developed by Oxford University and British-Swedish company AstraZeneca and manufactured by Serum Institute of India (SII) in Pune.
India is also looking at four other vaccines to be rolled out in the future. So far, the government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively, according to reports.
News Source : OECD
